2. QUALITATIVE AND QUANTITATIVE COMPOSITION

ADVANTAN Presentation Uses - Medsafe

ADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.

  Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate

LOXALATE 1. Product Name - Medsafe Home Page

Page 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.

  Risks, Combination

DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …

New Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …

  Sheet, Data, Data sheet, Clexane

SEPTANEST Articaine hydrochloride 4% with …

SEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.

  Articaine

BOOSTRIX - Medsafe Home Page

1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.

  Information, Boostrix

NEW ZEALAND DATA SHEET - Medsafe

NEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a

  Cymevene

Edition Draft - Medsafe

Part 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for

  Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice

Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …

New Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …

  Product, Name, Sheet, Data, Data sheet 1 product name

NEW ZEALAND DATA SHEET MESTINON® - Medsafe

NEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to

  Myasthenia, Gravis, Myasthenia gravis, Mestinon

DATA SHEET PREDNISONE - Medsafe

• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since

  Myasthenia, Gravis, Myasthenia gravis, Prednisone

METRONIDAZOLE INTRAVENOUS INFUSION

Baxter Product Information Metronidazole PI Amended 12 Nov 2012 Page 1 of 11 METRONIDAZOLE INTRAVENOUS INFUSION . NAME OF THE MEDICINE

  Metronidazole

What You Should Know About Bacterial Vaginosis

FemaleThe Patient® W hat’s the most common vaginal infection? Nope, it’s not a yeast infection! Bacterial vaginosis (BV) is the most frequent cause of abnormal

  Bacterial, Vaginosis, Bacterial vaginosis

Tricomoniasis vaginal. - medigraphic.com

Rev Mex Patol Clin, Vol. 53, Núm. 3, pp 151-156 • Julio - Septiembre, 2006 Carrada-Bravo T. Tricomoniasis vaginal 153 edigraphic.com Figura 1. La enferma presentó flujo espumoso y amarillento,

New Zealand Data Sheet - Medsafe

New Zealand Data Sheet . Arrow - Ornidazole. Ornidazole Tablets 500 mg Antimicrobial agent for the treatment of infections due to trichomonads,

  Ornidazole

Summary of 2015 - Centers for Disease Control and Prevention

These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases. This summary is intended as a source of clinical guidance.

  Center, Control, Centers for disease control and prevention, Disease, Prevention

Sexually Transmitted Diseases Treatment Guidelines 2010

Vol. 59 / RR-12 Recommendations and Reports 1. Sexually Transmitted Diseases Treatment Guidelines, 2010. Prepared by Kimberly A. Workowski, MD. 1,2

  Guidelines, Treatment, Disease, Sexually, Transmitted, Sexually transmitted diseases treatment guidelines